Abstract

The conversion of endogenous alpha-synuclein (asyn) to pathological asyn-enriched aggregates is a hallmark of Parkinson’s disease (PD). These inclusions can be detected in the central and enteric nervous system (ENS). Moreover, gastrointestinal symptoms can appear up to 20 years before the diagnosis of PD. The dual-hit hypothesis posits that pathological asyn aggregation starts in the ENS, and retrogradely spreads to the brain. In this study, we tested this hypothesis by directly injecting preformed asyn fibrils into the duodenum wall of wild-type rats and transgenic rats with excess levels of human asyn. We provide a meticulous characterization of the bacterial artificial chromosome (BAC) transgenic rat model with respect to initial propagation of pathological asyn along the parasympathetic and sympathetic pathways to the brainstem, by performing immunohistochemistry at early time points post-injection. Induced pathology was observed in all key structures along the sympathetic and parasympathetic pathways (ENS, autonomic ganglia, intermediolateral nucleus of the spinal cord (IML), heart, dorsal motor nucleus of the vagus, and locus coeruleus (LC)) and persisted for at least 4 months post-injection. In contrast, asyn propagation was not detected in wild-type rats, nor in vehicle-injected BAC rats. The presence of pathology in the IML, LC, and heart indicate trans-synaptic spread of the pathology. Additionally, the observed asyn inclusions in the stomach and heart may indicate secondary anterograde propagation after initial retrograde spreading. In summary, trans-synaptic propagation of asyn in the BAC rat model is fully compatible with the “body-first hypothesis” of PD etiopathogenesis. To our knowledge, this is the first animal model evidence of asyn propagation to the heart, and the first indication of bidirectional asyn propagation via the vagus nerve, i.e., duodenum-to-brainstem-to-stomach. The BAC rat model could be very valuable for detailed mechanistic studies of the dual-hit hypothesis, and for studies of disease modifying therapies targeting early pathology in the gastrointestinal tract.

Highlights

  • Parkinson’s disease (PD) is the second most common neurodegenerative disease after Alzheimer’s disease

  • At 4 months post-injection, we detected in preformed asyn fibrils (PFF)- and PBSinjected bacterial artificial chromosome (BAC) rats alike marked asyn immunoreactivity in the olfactory bulb, motor, frontal, parietal, occipital, and entorhinal cortex, striatum, thalamus, hippocampus, hypothalamus, and the substantia nigra (SN)

  • The BACPFF rats showed more intense asyn staining in the SN pars reticulata (SNr) than the BACPBS rats, and only the BACPFF rats exhibited distinct asyn pathology in the dorsal motor nucleus of the vagus (DMV) and the locus coeruleus (LC)

Read more

Summary

Introduction

Parkinson’s disease (PD) is the second most common neurodegenerative disease after Alzheimer’s disease. The dual-hit hypothesis proposes that the first inclusions form in the olfactory bulb and peripheral autonomic nerve endings of the gut, thereby explaining why the dorsal motor nucleus of the vagus (DMV) seems to be affected early in most cases of PD [9, 10]. This hypothesis is supported by several lines of evidence. The dual-hit hypothesis remains controversial, and is very difficult to prove conclusively in human patients due to the multifactorial etiology and the extended prodromal phase of PD, which may span 20 years or more [1, 8, 12, 44, 50]

Methods
Results
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call